Table 2

History of TV diagnostics

First use	Assay	Additional details	Sensitivity (men)	Sensitivity (women)	Specificity (men)	Specificity (women)
1837	Wet mount microscopy			36.4–82.0%^{w3 w23 w24}		99.1–100.0%^{w3 w23 w24}
1949	Culture	Diamond's media	56.0–100.0%^{w3 w4} 7	95.7%7	100.0%^{w3 w4}	100.0%^w3 7
1993	Culture	InPouch TV (BioMed Diagnostics)		69.7–73.3%^{w3 w25}		100.0%^{w3 w25}
1998	NAAT	APTIMA TV (Gen-Probe, San Diego, California, USA)	91.7%^w3	98.6%^w3	86.7–96.9%^w3	92.5–96.0%^w3
		PCR: Urine sample	91.7–100.0%3, ^{w3 w4} 7 17	90.8–100.0%^{w3 w23 w26} 17	88.0–99.4%^{w3 w4} 7	93.4–99.2%^{w3 w23 w26}
		PCR: Urogenital swab	81.6–91.7%^{w3 w27}	97.8–98.6%^{w3 w4}	94.9–95.5%^{w3 w27}	97.4–97.8%^{w3 w4}
2002	Immunochromatographic antigen detection assay	OSOM Trichmonas Rapid Test (Sekisui Diagnostics, Framingham, Massachusetts, USA)	Limited to vaginal specimens	83.3–98.0%^w28 30	Limited to vaginal specimens	98.9–99.4%^w28 30
2002		XenoStrip-Tv (Xenotype Diagnostics, San Antonio , Texas, USA)		66.7–90.0%^{w23 w26 w29}		92.5–100.0%^{w23 w26 w29}
2011	NAAT	FDA-cleared APTIMA TV (Gen-Probe, San Diego, California, USA)	96.0%^w3	95.2–100.0%^{w17 w30}	90.5–96.3%^w3	98.0–100.0%^{w17 w30}

NAAT, Nucleic acid amplification test.